Panel Backs FDA’s Suggestion Of Class II Stapler Status

A US FDA panel unanimously agreed that surgical staplers should be reclassified into class II on 30 May, backing FDA recommendations.

Surgical staplers should be regulated as class II devices, a US Food and Drug Association panel agreed on 30 May.

The General & Plastic Surgery Devices Advisory Committee met to discuss the FDA’s April recommendation the staplers be upclassified to...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

Already a subscriber?